LYMPHOMA, LARGE B-CELL, DIFFUSE
Clinical trials for LYMPHOMA, LARGE B-CELL, DIFFUSE explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, LARGE B-CELL, DIFFUSE trials appear
Sign up with your email to follow new studies for LYMPHOMA, LARGE B-CELL, DIFFUSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough brain cancer trial tests targeted drug duos
Disease control OngoingThis study is testing whether adding either lenalidomide or ibrutinib to standard chemotherapy works better for adults with newly diagnosed primary brain lymphoma. The first part determines safe drug doses, while the second part compares how well patients respond to each combinat…
Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE
Phase: PHASE1, PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
First-in-Human trial tests experimental drug for Tough-to-Treat blood cancers
Disease control OngoingThis is the first study testing a new experimental drug called PF-08046044/SGN-35C in people with advanced lymphoma that has returned or stopped responding to standard treatments. The trial will enroll 57 adults with specific types of lymphoma to determine the safest dose, unders…
Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC